These results are important for three reasons: First, these models functionally underscore the strong gains in fitness and drug resistance that MM cells can potentially acquire from any type of single TP53 lesion, and which supports their rise to subclonal prominence. The gene discussed is TP53; the disease is Miyoshi myopathy.